Skip to main content
Clinical Trials/NCT06069011
NCT06069011
Completed
N/A

Improving Access to Quality Care for Children and Adolescents Presenting to the Pediatric Emergency Department With Musculoskeletal Problems: a Pilot Randomized Control Trial

McGill University Health Centre/Research Institute of the McGill University Health Centre1 site in 1 country66 target enrollmentSeptember 18, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Musculoskeletal Pain
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Enrollment
66
Locations
1
Primary Endpoint
Rate of consent
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The goal of this clinical trial is to compare two methods of managing low acuity musculoskeletal complaints in children and adolescents ages 6 to 17.99 years in the pediatric emergency department. The main question it aims to answer is whether delivering care in two methods is feasible. Participants will receive care while in the emergency department and will be followed for a period of 1-month post-presentation.

Registry
clinicaltrials.gov
Start Date
September 18, 2023
End Date
December 31, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Responsible Party
Principal Investigator
Principal Investigator

Isabelle Gagnon

Senior Investigator

McGill University Health Centre/Research Institute of the McGill University Health Centre

Eligibility Criteria

Inclusion Criteria

  • aged 6.00-17.99 years of age
  • present to the Montreal Children's Hospital Emergency Department with a suspected MSK complaint, traumatic or not
  • are given a triage score of 3 (urgent), 4 (less urgent), or 5 (nonurgent) according to the Canadian Triage and Acuity Scale (CTAS)
  • are able to communicate in French or English

Exclusion Criteria

  • present with a major MSK condition requiring urgent care (e.g., open fracture, open wound)
  • a red flag (e.g. progressive neurological disorder, infectious symptoms)
  • a co-morbid unstable condition.

Outcomes

Primary Outcomes

Rate of consent

Time Frame: through study completion an average of 4 weeks post-enrolment

rate of consented patients related to patients approached rate of randomization, feasibility of administration of outcomes

Completed outcome measures

Time Frame: through study completion an average of 4 weeks post-enrolment

proportion of participants who complete all outcome measures

Secondary Outcomes

  • Pain intensity on faces rating scale(through study completion an average of 4 weeks post-enrolment)
  • Pain interference with function PROMIS scale(through study completion an average of 4 weeks post-enrolment)

Study Sites (1)

Loading locations...

Similar Trials